17 August 2025 : Clinical Research
Evaluation of Inflammatory Biomarkers in Parotid Tumors
Aykut Ikinciogullari
ABCDEF 1*, Burak Hazir ABCDEF 1, Erdem Aggunlu ABCDEF 1, Mustafa Colak ACDEF 1, Serdar Ensari ADEF 1, Haci Huseyin Dere ADEF 1
DOI: 10.12659/MSM.947334
Med Sci Monit 2025; 31:e947334
Tables 1 Histological subtypes and sizes of the tumors among patients.
| Patients, n (%) | Mean tumor size (cm) | |||
|---|---|---|---|---|
| Benign | Pleomorphic adenoma | 97 (47.09) | 2.72 | |
| Warthin’s | 62 (30.1) | 3.53 | ||
| Basal cell adenoma | 7 (3.4) | 1.64 | ||
| Lymphoepithelial cyst | 6 (2.91) | 2.37 | ||
| Cystadenoma | 2 (0.97) | 2.25 | ||
| Schwannoma | 1 (0.49) | 2.2 | ||
| Sialolipoma | 1 (0.49) | 4.0 | ||
| Hemangioma | 1 (0.49) | 3.1 | ||
| Total/average | 177 (85.92) | 2.95 | ||
| Malignant | Low | Mucoepidermoid carcinoma | 6 (2.91) | 1.58 |
| Acinic cell carcinoma | 2 (0.97) | 2.35 | ||
| Adenoid cystic carcinoma | 1 (0.49) | 3.0 | ||
| Epithelial-myoepithelial carcinoma | 1 (0.49) | 1.1 | ||
| Myoepithelial carcinoma | 1 (0.49) | 6.2 | ||
| Basal cell adenocarcinoma | 1 (0.49) | 2.0 | ||
| Secretory carcinoma | 1 (0.49) | 1.7 | ||
| Total/average | 13 (6.31) | 2.17 | ||
| High | Mucoepidermoid carcinoma | 4 (1.94) | 3.75 | |
| Squamous cell carcinoma | 2 (0.97) | 6.0 | ||
| Salivary duct carcinoma | 4 (1.94) | 1.52 | ||
| Adenocarcinoma (NOS) | 2 (0.97) | 3.5 | ||
| Total/average | 12 (5.83) | 3.34 | ||
| Lymphoma | 4 (1.94) | 3.35 | ||